Obesity Drug Stocks Go Wild After Belviq Approval
Investors.com
Vivus and Arena: A Tale of Dueling FDA Panel Minutes
TheStreet.com
Arena Pharma And The Fat Lady's Song
TheStreet.com
No Delay for Arena?
Motley Fool
Will Patience Pay for Arena’s Biggest Fans Awaiting the Final Answer?
Wall Street Cheat Street
Why are Obesity Stocks Suddenly So Hot?
Motley Fool

